Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
T Bachelot, E Ciruelos, A Schneeweiss, et al.
Blood
|
December 1, 1996
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype
D Ben-Yehuda, S Krichevsky, O Caspi, et al.
Clinical Genetics
|
November 29, 2014
Genetic features of Lynch syndrome in the Israeli population
Y Goldberg, I Barnes-Kedar, I Lerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2
O Merimsky, E Gez, R Weitzen, et al.
American Journal of Human Genetics
|
October 3, 1998
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes
E Friedman, R Bar-Sade Bruchim, A Kruglikova, et al.
Human Heredity
|
August 22, 2001
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families
A P Manning, D Abelovich, P Ghadirian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 5, 2021
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
D Miles, E Ciruelos, A Schneeweiss, et al.
Breast Cancer Research and Treatment
|
March 12, 2022
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews
S Lieberman, R Chen-Shtoyerman, Z Levi, et al.
Journal of Skin Cancer
|
February 1, 2013
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma
M Klein, M Lotem, T Peretz, et al.
ESMO Open
|
November 14, 2021
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer
M Condorelli, M Bruzzone, M Ceppi, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
T Bachelot, E Ciruelos, A Schneeweiss, et al.
Blood
|
December 1, 1996
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype
D Ben-Yehuda, S Krichevsky, O Caspi, et al.
Clinical Genetics
|
November 29, 2014
Genetic features of Lynch syndrome in the Israeli population
Y Goldberg, I Barnes-Kedar, I Lerer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2
O Merimsky, E Gez, R Weitzen, et al.
American Journal of Human Genetics
|
October 3, 1998
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes
E Friedman, R Bar-Sade Bruchim, A Kruglikova, et al.
Human Heredity
|
August 22, 2001
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families
A P Manning, D Abelovich, P Ghadirian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 5, 2021
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
D Miles, E Ciruelos, A Schneeweiss, et al.
Breast Cancer Research and Treatment
|
March 12, 2022
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews
S Lieberman, R Chen-Shtoyerman, Z Levi, et al.
Journal of Skin Cancer
|
February 1, 2013
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma
M Klein, M Lotem, T Peretz, et al.
ESMO Open
|
November 14, 2021
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer
M Condorelli, M Bruzzone, M Ceppi, et al.
Page
of 11